Expression pattern of a homeotic gene, HOXA5, in normal breast and in breast tumors

Cellular Oncology

Volumn 28, Issue 5-6, 2006, Pages 305-313

  Henderson, Gregory S ^a,e   Van Diest, Paul J ^b   Burger, Horst ^c   Russo, Jose ^d   Raman, Venu ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY OF MÜNSTER   (Germany)

^d FOX CHASE CANCER CENTER   (United States)

^e NEW HANOVER REGIONAL MEDICAL CENTER   (United States)

Author keywords

Breast; Epidermal growth factor receptor; Homeotic gene

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEIN; PROTEIN HOXA5;

ADOLESCENT; ADULT; ARTICLE; BREAST; BREAST CARCINOMA; BREAST EPITHELIUM; BREAST TUMOR; CANCER SURVIVAL; CARCINOGENESIS; CELL DIFFERENTIATION; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE; GENE EXPRESSION; HOMEOBOX; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LACTATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REPRODUCTION; WOMEN'S HEALTH;

BREAST; BREAST NEOPLASMS; CELL PROLIFERATION; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, HOMEOBOX; HOMEODOMAIN PROTEINS; HUMANS; LACTATION; POSTMENOPAUSE; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA, MESSENGER; SURVIVAL ANALYSIS;

EID: 33845643187     PISSN: 15705870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. C. Abate-Shen, Deregulated homeobox gene expression in cancer: cause or consequence? Nat. Rev. Cancer 2 (2002), 777-785.
2. C. Abramovich and R.K. Humphries, Hox regulation of normal and leukemic hematopoietic stem cells, Curr. Opin. Hematol. 12 (2005), 210-216.
3. Z.N. Akin and A.J. Nazarali, Hox genes and their candidate downstream targets in the developing central nervous system, Cell. Mol. Neurobiol. 25 (2005), 697-741.
4. R. Anbazhagan and V. Raman, Homeobox genes: molecular link between congenital anomalies and cancer, Eur. J. Cancer 33 (1997), 635-637.
5. S. Biffo and E. Tolosano, The use of radioactively labelled riboprobes for in situ hybridization: background and examples of application, Liver 12 (1992), 230-237.
6. H. Burger, C. Poremba, R. Diallo et al., [Establishing a cytogenetic and morphological progression models of invasive breast cancer. Comparative genomic hybridization (CGH) in malignant and premalignant tumors of the female breast], Pathologe 21 (2000), 375-382.
7. M. Cantile, G. Pettinato, A. Procino et al., In vivo expression of the whole HOX gene network in human breast cancer, Eur. J. Cancer 39 (2003), 257-264.
8. G. Carpenter, Nuclear localization and possible functions of receptor tyrosine kinases, Curr. Opin. Cell. Biol. 15 (2003), 143-148.
9. H. Chen, S. Chung and S. Sukumar, HOXA5-induced apoptosis in breast cancer cells is mediated by caspases 2 and 8, Mol. Cell Biol. 24 (2004), 924-935.
10. C. Cillo, P. Barba, G. Freschi et al., HOX gene expression in normal and neoplastic human kidney, Int. J. Cancer 51 (1992), 892-897.
11. S. Cohen, R.A. Fava and S.T. Sawyer, Purification and characterization of epidermal growth factor receptor/protein kinase from normal mouse liver, Proc. Natl. Acad. Sci. USA 79 (1982), 6237-6241.
12. B.D. Cohen, C.B. Siegall, S. Bacus et al., Role of epidermal growth factor receptor family members in growth and differentiation of breast carcinoma, Biochem. Soc. Symp. 63 (1998), 199-210.
13. C.C. de la Cruz, A. Der-Avakian, D.D. Spyropoulos et al., Targeted disruption of Hoxd9 and Hoxd10 alters locomotor behavior, vertebral identity, and peripheral nervous system development, Dev. Biol. 216 (1999), 595-610.
14. A.P. Davis and M.R. Capecchi, A mutational analysis of the 5′ HoxD genes: dissection of genetic interactions during limb development in the mouse, Development 122 (1996), 1175-1185.
15. J.S. de Jong, P.J. van Diest, P. van der Valk et al., Expression of growth factors, growth-inhibiting factors, and their receptors in invasive breast cancer. II: Correlations with proliferation and angiogenesis, J. Pathol. 184 (1998), 53-57.
16. J. Deschamps and F. Meijlink, Mammalian homeobox genes in normal development and neoplasia, Crit. Rev. Oncog. 3 (1992), 117-173.
17. G. De Vita, P. Barba, N. Odartchenko et al., Expression of homeobox-containing genes in primary and metastatic colorectal cancer, Eur. J. Cancer 29A (1993), 887-893.
18. E.A. Eklund, The role of HOX genes in myeloid leukemogenesis, Curr. Opin. Hematol. 13 (2006), 67-73.
19. F.R. Goodman, Congenital abnormalities of body patterning: embryology revisited, Lancet 362 (2003), 651-662.
20. J.M. Greer and M.R. Capecchi, Hoxb8 is required for normal grooming behavior in mice, Neuron 33 (2002), 23-34.
21. K. Hsu and A.T. Look, Turning on a dimer: new insights into MLL chimeras, Cancer Cell. 4 (2003), 81-83.
22. C. Kappen, Disruption of the homeobox gene Hoxb-6 in mice results in increased numbers of early erythrocyte progenitors, Am. J. Hematol. 65 (2000), 111-118.
23. P.T. La Celle and R.R. Polakowska, Human homeobox HOXA7 regulates keratinocyte transglutaminase type 1 and inhibits differentiation, J. Biol. Chem. 276 (2001), 32844-32853.
24. H.W. Lo, W. Xia, Y. Wei et al., Novel prognostic value of nuclear epidermal growth factor receptor in breast cancer, Cancer Res. 65 (2005), 338-348.
25. M. Mark, F.M. Rijli and P. Chambon, Homeobox genes in embryogenesis and pathogenesis, Pediatr. Res. 42 (1997), 421-429.
26. A. Michalczyk, R.W. Brown, J.P. Collins et al., Lactation affects expression of intermediate filaments in human breast epithelium, Differentiation 67 (2001), 41-49.
27. R. Morgan, Hox genes: a continuation of embryonic patterning? Trends Genet. 22 (2006), 67-69.
28. D.P. Mortlock and J.W. Innis, Mutation of HOXA13 in hand-foot-genital syndrome, Nat. Genet. 15 (1997), 179-180.
29. D.P. Mortlock, L.C. Post and J.W. Innis, The molecular basis of hypodactyly (Hd): a deletion in Hoxa 13 leads to arrest of digital arch formation, Nat. Genet. 13 (1996), 284-289.
30. J. Packeisen, H. Buerger, R. Krech et al., Tissue microarrays: a new approach for quality control in immunohistochemistry, J. Clin. Pathol. 55 (2002), 613-615.
31. J. Packeisen, E. Korsching, H. Herbst et al., Demystified . . . tissue microarray technology, Mol. Pathol. 56 (2003), 198-204.
32. J.C. Pearson, D. Lemons and W. McGinnis, Modulating Hox gene functions during animal body patterning, Nat. Rev. Genet. 6 (2005), 893-904.
33. V. Raman, S.A. Martensen, D. Reisman et al., Compromised HOXA5 function can limit p53 expression in human breast tumours, Nature 405 (2000), 974-978.
34. C.E. Reilly, Disruption of Hoxb8 gene leads to obsessive grooming behavior, J. Neurol. 249 (2002), 499-501.
35. J. Russo, Y.F. Hu, I.D. Silva et al., Cancer risk related to mammary gland structure and development, Microsc. Res. Tech. 52 (2001), 204-223.
36. T. Shimamoto, K. Ohyashiki, K. Toyama et al., Homeobox genes in hematopoiesis and leukemogenesis, Int. J. Hematol. 67 (1998), 339-350.
37. I.A. Stasinopoulos, Y. Mironchik, A. Raman et al., HOXA5-twist interaction alters p53 homeostasis in breast cancer cells, J. Biol. Chem. 280 (2005), 2294-2299.
38. T. Svingen and K.F. Tonissen, Altered HOX gene expression in human skin and breast cancer cells, Cancer Biol. Ther. 2 (2003), 518-523.
39. C. Tiberio, P. Barba, M.C. Magli et al., HOX gene expression in human small-cell lung cancers xenografted into nude mice, Int. J. Cancer 58 (1994), 608-615.
40. E. Tournier-Lasserve, W.F. Odenwald, J. Garbern et al., Remarkable intron and exon sequence conservation in human and mouse homeobox Hox 1.3 genes, Mol. Cell. Biol. 9 (1989), 2273-2278.
41. A. Veraksa, M. Del Campo and W. McGinnis, Developmental patterning genes and their conserved functions: from model organisms to humans, Mol. Genet. Metab. 69 (2000), 85-100.
42. G.M. Wahba, S.L. Hostikka and E.M. Carpenter, The paralogous Hox genes Hoxa10 and Hoxd10 interact to pattern the mouse hindlimb peripheral nervous system and skeleton, Dev. Biol. 231 (2001), 87-102.